The IRIS V Study: Pioglitazone Improves Systemic Chronic Inflammation in Patients with Type 2 Diabetes Under Daily Routine Conditions

Karagiannis, Efstrathios; Pfützner, Andreas; Forst, Thomas; Lübben, Georg; Roth, Werner; Grabellus, Martin; Flannery, Manja; Schöndorf, Thomas

research article

oai:pub.h-brs.de:2885

The IRIS V Study: Pioglitazone Improves Systemic Chronic Inflammation in Patients with Type 2 Diabetes Under Daily Routine Conditions

Authors: Efstrathios Karagiannis
Andreas Pfützner
Thomas Forst
Georg Lübben
Werner Roth
Martin Grabellus
Manja Flannery
Thomas Schöndorf
Publication date: 3 May 2008
Publisher
Doi

Abstract

Abstract is not available.

Similar works

Full text

pub H-BRS - Publikationsserver der Hochschule Bonn-Rhein-Sieg

oai:pub.h-brs.de:2885

Last time updated on 10/03/2017

This paper was published in pub H-BRS - Publikationsserver der Hochschule Bonn-Rhein-Sieg.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.